Hillcoat BL - Search Results

1

Cisplatin plus VP 16-213 in advanced ovarian carcinoma.

Harnett PR, Bell DR, Hillcoat BL, Woods RL, Levi JA, Rome RM, Campbell JC, Tattersall MH. Harnett PR, et al. Among authors: hillcoat bl. Gynecol Oncol. 1988 Jun;30(2):159-62. doi: 10.1016/0090-8258(88)90019-4. Gynecol Oncol. 1988. PMID: 3371739

2

A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract.

Hillcoat BL, Raghavan D, Matthews J, Kefford R, Yuen K, Woods R, Olver I, Bishop J, Pearson B, Coorey G, et al. Hillcoat BL, et al. J Clin Oncol. 1989 Jun;7(6):706-9. doi: 10.1200/JCO.1989.7.6.706. J Clin Oncol. 1989. PMID: 2654329 Clinical Trial.

3

Phase II trial of VP-16-213 in advanced ovarian carcinoma.

Hillcoat BL, Campbell JJ, Pepperell R, Quinn MA, Bishop JF, Day A. Hillcoat BL, et al. Gynecol Oncol. 1985 Oct;22(2):162-6. doi: 10.1016/0090-8258(85)90022-8. Gynecol Oncol. 1985. PMID: 4054715

4

Mitomycin and mitoxantrone in previously treated patients with advanced breast cancer.

Bishop JF, Raghavan D, Woods R, Coates A, Burns I, Jeal PN, Hillcoat BL, Tattersall MN. Bishop JF, et al. Among authors: hillcoat bl. Cancer Treat Rep. 1987 Feb;71(2):191-3. Cancer Treat Rep. 1987. PMID: 2433037

5

Preparation and administration of antineoplastic agents. Risks and recommendations.

Hillcoat BL, Levi J, Snyder R. Hillcoat BL, et al. Med J Aust. 1983 Apr 30;1(9):424-6. Med J Aust. 1983. PMID: 6835161 No abstract available.

6

A phase I study of doxifluridine as a five-day stepped-dose continuous infusion.

Olver IN, Reece PA, Bishop JF, Morris RG, Hillcoat BL, Guentert TW. Olver IN, et al. Among authors: hillcoat bl. Am J Clin Oncol. 1990 Aug;13(4):308-11. doi: 10.1097/00000421-199008000-00008. Am J Clin Oncol. 1990. PMID: 2143051

7

A dose finding study of prochlorperazine as an antiemetic for cancer chemotherapy.

Olver IN, Webster LK, Bishop JF, Clarke J, Hillcoat BL. Olver IN, et al. Among authors: hillcoat bl. Eur J Cancer Clin Oncol. 1989 Oct;25(10):1457-61. doi: 10.1016/0277-5379(89)90104-1. Eur J Cancer Clin Oncol. 1989. PMID: 2591437

8

Priorities in experimental therapeutics--a surfeit of riches.

Hillcoat BL. Hillcoat BL. Eur J Cancer Clin Oncol. 1989 Sep;25(9):1263-9. doi: 10.1016/0277-5379(89)90071-0. Eur J Cancer Clin Oncol. 1989. PMID: 2680511 Review.

9

Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.

Bishop JF, Wolf M, Matthews JP, Scott K, Ackland S, Yuen K, Morton C, Hillcoat BL, Cooper IA. Bishop JF, et al. Among authors: hillcoat bl. Cancer Treat Rep. 1987 Nov;71(11):1007-11. Cancer Treat Rep. 1987. PMID: 3315193 Clinical Trial.

10

Treatment of advanced malignant hemangiopericytoma with combination adriamycin and DTIC: a report of four cases.

Beadle GF, Hillcoat BL. Beadle GF, et al. Among authors: hillcoat bl. J Surg Oncol. 1983 Mar;22(3):167-70. doi: 10.1002/jso.2930220306. J Surg Oncol. 1983. PMID: 6682161

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters